XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Changes In Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Common Stock To Be Issued [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 93 $ 2,373,918 $ 16,340 $ (3,631,442) $ (1,241,091)
Beginning balance, shares at Dec. 31, 2019 1,213 9,269,996        
Common stock issued for restricted stock units 459,589 459,589
Common stock issued for restricted stock units, shares   21,530        
Dividends on Series A preferred stock (103,062) (103,062)
Net loss (805,732) (805,732)
Ending Balance, value at Dec. 31, 2020 $ 93 2,833,507 16,340 (4,540,236) (1,690,296)
Ending balance, shares at Dec. 31, 2020 1,213 9,291,526        
Common stock issued for restricted stock units   122,517 122,517
Dividends on Series A preferred stock   (25,768) (25,768)
Net loss (129,324) (129,324)
Ending Balance, value at Mar. 31, 2021 $ 93 2,956,024 16,340 (4,695,328) (1,722,871)
Ending balance, shares at Mar. 31, 2021 1,213 9,291,526        
Beginning balance, value at Dec. 31, 2020 $ 93 2,833,507 16,340 (4,540,236) (1,690,296)
Beginning balance, shares at Dec. 31, 2020 1,213 9,291,526        
Net loss           (693,086)
Ending Balance, value at Sep. 30, 2021 $ 93 3,201,058 16,340 (5,310,626) (2,093,135)
Ending balance, shares at Sep. 30, 2021 1,213 9,308,646        
Beginning balance, value at Dec. 31, 2020 $ 93 2,833,507 16,340 (4,540,236) (1,690,296)
Beginning balance, shares at Dec. 31, 2020 1,213 9,291,526        
Warrants issued for financing costs 407,293 407,293
Common stock issued for restricted stock units 490,067 490,067
Common stock issued for restricted stock units, shares   20,626        
Dividends on Series A preferred stock (103,062) (103,062)
Net loss (1,152,134) $ (1,152,134)
Common stock issued for cash, shares           210,000
Stock based compensation (As Restated) 420,000 $ 420,000
Ending Balance, value at Dec. 31, 2021 $ 93 4,150,867 16,340 (5,795,432) (1,628,132)
Ending balance, shares at Dec. 31, 2021 1,213 9,312,152        
Beginning balance, value at Mar. 31, 2021 $ 93 2,956,024 16,340 (4,695,328) (1,722,871)
Beginning balance, shares at Mar. 31, 2021 1,213 9,291,526        
Common stock issued for restricted stock units 122,517 122,517
Common stock issued for restricted stock units, shares   7,738        
Dividends on Series A preferred stock (25,768) (25,768)
Net loss (346,801) (346,801)
Ending Balance, value at Jun. 30, 2021 $ 93 3,078,541 16,340 (5,067,897) (1,972,923)
Ending balance, shares at Jun. 30, 2021 1,213 9,299,264        
Common stock issued for restricted stock units 122,517 122,517
Common stock issued for restricted stock units, shares   9,382        
Dividends on Series A preferred stock (25,768) (25,768)
Net loss (216,961) (216,961)
Ending Balance, value at Sep. 30, 2021 $ 93 3,201,058 16,340 (5,310,626) (2,093,135)
Ending balance, shares at Sep. 30, 2021 1,213 9,308,646        
Beginning balance, value at Dec. 31, 2021 $ 93 4,150,867 16,340 (5,795,432) (1,628,132)
Beginning balance, shares at Dec. 31, 2021 1,213 9,312,152        
Warrants issued for financing costs 319,643 319,643
Common stock issued for conversion of accrued interest convertible debt 16,340 (16,340)
Common stock issued for conversion of accrued interest convertible debt, shares   839        
Common stock issued for restricted stock units 166,533 166,533
Common stock issued for restricted stock units, shares   5,104        
Dividends on Series A preferred stock (25,768) (25,768)
Net loss (681,839) (681,839)
Ending Balance, value at Mar. 31, 2022 $ 93 4,653,383 (6,503,039) (1,849,563)
Ending balance, shares at Mar. 31, 2022 1,213 9,318,095        
Beginning balance, value at Dec. 31, 2021 $ 93 4,150,867 16,340 (5,795,432) (1,628,132)
Beginning balance, shares at Dec. 31, 2021 1,213 9,312,152        
Net loss           (2,277,539)
Ending Balance, value at Sep. 30, 2022 $ 136 16,548,719 (8,143,980) 8,404,875
Ending balance, shares at Sep. 30, 2022 13,586,393        
Beginning balance, value at Mar. 31, 2022 $ 93 4,653,383 (6,503,039) (1,849,563)
Beginning balance, shares at Mar. 31, 2022 1,213 9,318,095        
Common stock issued for restricted stock units 166,533 166,533
Common stock issued for restricted stock units, shares   5,104        
Dividends on Series A preferred stock (25,768) (25,768)
Net loss (597,275) (597,275)
Ending Balance, value at Jun. 30, 2022 $ 93 4,819,916 (7,126,082) (2,306,073)
Ending balance, shares at Jun. 30, 2022 1,213 9,323,199        
Warrants issued for financing costs 92,598 92,598
Common stock issued for conversion of accrued interest convertible debt $ 1 588,523 588,524
Common stock issued for conversion of accrued interest convertible debt, shares   147,500        
Common stock issued for restricted stock units 23,667 23,667
Common stock issued for restricted stock units, shares   1,045        
Dividends on Series A preferred stock (19,473) (19,473)
Net loss (998,425) (998,425)
Common stock issued for cash $ 14 10,031,401 10,031,415
Common stock issued for cash, shares   1,409,771        
Warrants exercised for cash $ 14 14,084 14,098
Warrants exercised for cash, shares   1,409,771        
Common stock issued for exercise of warrants with settlement of notes payable $ 9 576,467 576,476
Common stock issued for exercise of warrants with settlement of notes payable, shares   857,780        
Common shares issued for dividends on and conversion of Series A preferred stock $ 5 402,064 402,068
Common shares issued for dividends on and conversion of Series A preferred stock, shares (1,213) 437,327        
Ending Balance, value at Sep. 30, 2022 $ 136 $ 16,548,719 $ (8,143,980) $ 8,404,875
Ending balance, shares at Sep. 30, 2022 13,586,393